Adjuvant Aumolertinib in Patients with Completely Resected, Stage IA2-IIIA Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations

被引：0
|
作者：
Zhang, Q. [1 ]
Ke, L. [1 ]
Huang, S. [2 ]
Yang, Y. [1 ]
He, T. [1 ]
Sun, H. [3 ]
Wu, Z. [1 ]
Zhang, X. [4 ]
Lv, W. [1 ]
Hu, J. [1 ]
Ye, J. [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China
[3] Zhejiang Univ, Taizhou Hosp, Taizhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Aumolertinib; Adjuvant; Uncommon EGFR mutations;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07E.07
引用
收藏
页码：S555 / S556
页数：2
相关论文
共 50 条
  • [41] Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
    K Nakagawa
    H Tada
    A Akashi
    T Yasumitsu
    K Iuchi
    T Taki
    K Kodama
    British Journal of Cancer, 2006, 95 : 817 - 821
  • [42] Postoperative Radiotherapy in Completely Resected Stage IIIA-N2 Non-Small Cell Lung Cancer
    Ahn, S.
    Na, K.
    Kim, Y.
    Song, S.
    Oh, I.
    Park, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2180 - S2181
  • [43] EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
    Tang, Wenjie
    Li, Xiaolin
    Xi, Xueqi
    Sun, Xindong
    Liu, Jie
    Zhang, Jian
    Wang, Chungang
    Yu, Jinming
    Xie, Peng
    LUNG CANCER, 2019, 136 : 6 - 14
  • [44] Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review
    Bradbury, Penelope
    Sivajohanathan, Duvaraga
    Chan, Adrien
    Kulkarni, Swati
    Ung, Yee
    Ellis, Peter M.
    CLINICAL LUNG CANCER, 2017, 18 (03) : 259 - +
  • [45] Adjuvant treatment of completely resected stage IB-IIIA non-small-cell lung cancer. A retrospective study with cisplatin or carboplatin and oral vinorelbine.
    Magnet, Friederike Sophie
    Alten, Nina
    Bachinger, Andreas
    Engel-Riedel, Walburga
    Ludwig, Corinna
    Stoelben, Erich
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer
    Na, Im Il
    Rho, Jin Kyung
    Choi, Yun Jung
    Kim, Cheol Hyeon
    Koh, Jae Soo
    Ryoo, Baek-Yeol
    Yang, Sung Hyun
    Lee, Jae Cheol
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (03) : 393 - 399
  • [47] Effectiveness of icotinib against non-small-cell lung cancer with uncommon EGFR mutations.
    Zhou, Shengyu
    Hu, Xingsheng
    Wang, Yan
    Li Junling
    Zhou, Liqiang
    Hao, Xuezhi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Potential Usage of Afanitib in the Treatment of Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Harada, Taishi
    Yamaba, Yukiko
    Hayata, Hiroki
    Okuda, Takashi
    Kimura, Yoshishige
    Komaki, Toshiyuki
    Kagawa, Keizo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1241 - S1241
  • [49] Management of non-small-cell lung cancer (stage IIIa)
    Gridelli, C
    Rossi, A
    Guerriero, C
    Ferrara, C
    Del Gaizo, F
    Colantuoni, G
    Salerno, V
    Nicolella, D
    TUMORI JOURNAL, 2003, : S103 - S105
  • [50] Adjuvant Aumolertinib in Resected EGFR-Mutated Non-Small Cell Lung Cancer: Impact on Residual GGO Lesions
    Ma, H.
    Huang, H.
    Feng, Y.
    Chen, S.
    Li, G.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S559 - S560
12345